Genomic Health Announces Publication Of Study Of Oncotype DX(R) In Node-Positive Brea
Genomic Health, Inc. (Nasdaq: GHDX) announced that The Lancet Oncology published positive results from a study of Oncotype DX(®) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical trials cooperative group...
More... |
All times are GMT -7. The time now is 06:02 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021